Nokol
Nokol
present in the specimen above the limit of detection. A negative result does not rule out
the possibility of COVID-19 and should not be used as the sole basis for treatment or
patient management decisions. If COVID-19 is still suspected, based on exposure history
together with other clinical findings, re-testing should be considered in consultation with
public health authorities. Laboratory test results should always be considered in the
context of clinical observations and epidemiological data in making a final diagnosis and
patient management decisions. Please review the "Fact Sheets" and FDA authorized labeling
available for health care providers and patients using the following websites:
https://www.questdiagnostics.com/home/Covid-19/HCP/NAAT/fact-sheet2
https://www.questdiagnostics.com/home/Covid-19/Patients/NAAT/ fact-sheet2 This test has
been authorized by the FDA under an Emergency Use Authorization (EUA) for use by authorized
laboratories. Due to the current public health emergency, Quest Diagnostics is receiving a
high volume of samples from a wide variety of swabs and media for COVID-19 testing. In
order to serve patients during this public health crisis, samples from appropriate clinical
sources are being tested. Negative test results derived from specimens received in non-
commercially manufactured viral collection and transport media, or in media and sample
collection kits not yet authorized by FDA for COVID-19 testing should be cautiously
evaluated and the patient potentially subjected to extra precautions such as additional
clinical monitoring, including collection of an additional specimen. Methodology: Nucleic
Acid Amplification Test (NAAT) includes PCR or TMA Additional information about COVID-19
can be found at the Quest Diagnostics website: www.QuestDiagnostics.com/Covid19. THIS TEST
WAS PERFORMED AT: QUEST DIAGNOSTICS LLC 200 FOREST STREET 3RD FLOOR,SUITE B MARLBOROUGH, MA
01752-3023 SALIM E KABAWAT,MD